Glycaemic variability, infections and mortality in a medical–surgical intensive care unit

Critical Care and Resuscitation

Volumn 16, Issue 1, 2014, Pages 13-23

  Donati, Abele ^a   Damiani, Elisa ^a   Domizi, Roberta ^a   Botticelli, Laura ^a   Castagnani, Roberta ^a   Gabbanelli, Vincenzo ^a   Nataloni, Simonetta ^a   Carsetti, Andrea ^a   Scorcella, Claudia ^a   Adrario, Erica ^a   Pelaia, Paolo ^a   Preiser, Jean Charles ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; ITALY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL RATE; UNIVERSITY HOSPITAL;

ADULT; AGED; BLOOD GLUCOSE; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; INTENSIVE CARE UNITS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SURVIVAL RATE;

EID: 84908230631     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009; 373: 1798-807.
2. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care 2013; 17: 305.
3. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.
4. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39.
5. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35: 1738-48.
6. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.
7. Ichai C, Preiser JC; Société Française d’Anesthésie-Réanimation; Société de Réanimation de langue Française; Experts Group. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care 2010; 14: R166.
8. Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154: 260-7.
9. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40: 3251-76.
10. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008-13.
11. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-52.
12. Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38: 838-42.
13. Ali NA, O’Brien JM Jr, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-21.
14. Dossett LA, Cao H, Mowery NT, et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008; 74: 679-85.
15. Zuo YY, Kang Y, Yin WH, et al. The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis. J Crit Care 2012; 27: 146-52.
16. Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 2012; 40: 3180-8.
17. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008; 9: 361-6.
18. Ali NA, Krinsley JS, Preiser JC. Glucose variability in critically ill patients. Yearbook of intensive care and emergency medicine 2009. Heidelberg: Springer, 2009: 728-37.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classication system. Crit Care Med 1985; 13: 818-29.
20. van Saene HK, Silvestri L, de la Cal MA. Infection control in the intensive care unit. 2nd ed. Heidelberg: Springer, 2005.
21. Service FJ, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-55.
22. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955-62.
23. Jansen TC, van Bommel J, Mulder PG, et al. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care 2008; 12: R160.
24. Joshi M, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-12.
25. Reddy AB, Srivastava SK, Ramana KV. Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages. Int J Biochem Cell Biol 2010; 42: 1039-45.
26. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989; 38: 1031-5.
27. Losser MR, Bernard C, Beaudeux JL, et al. Glucose modulates hemodynamic, metabolic, and inammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997; 83: 1566-74.
28. Meynaar IA, Eslami S, Abu-Hanna A, et al. Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: a multicenter cohort study. J Crit Care 2012; 27: 119-24.
29. Gabbanelli V, Pantanetti S, Donati A, et al. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol 2005; 71: 717-25.
30. Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care 2013; 17: R37.
31. Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care 2013; 17: R52.
32. Finfer S, Billot L. Managing blood glucose in critically ill patients with or without diabetes. Crit Care 2013; 17: 134.
33. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007; 30: 403-9.
34. Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem 2009; 55: 18-20.
35. Lundelin K, Vigil L, Bua S, et al. Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study. Crit Care Med 2010; 38: 849-54.
36. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007; 30: 1005-11.
37. Bagshaw SM, Bellomo R, Jacka MJ, et al; ANZICS CORE Management Committee. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009; 13: R91.